United Kingdom and Ireland
Our home market. Direct buyer relationships across department store, pharmacy chain and specialist beauty retail.
Eight regions, scoped one at a time
Every market on this page has a different constraint. Treating them as one “international” plan is the most expensive mistake we see.
| Region | Entry cities | Channels | Typical lead time |
|---|---|---|---|
| United Kingdom and Ireland | London, Dublin | Retail, DTC, marketplace | 8-14 weeks |
| DACH | Berlin, Munich, Zurich | Retail, DTC, marketplace | 14-20 weeks |
| Nordics | Stockholm, Copenhagen | Retail, DTC | 10-16 weeks |
| France | Paris | Retail, pharmacy, DTC | 16-24 weeks |
| Italy | Milan | Retail, wholesale, DTC | 14-20 weeks |
| North America | New York, Toronto | Retail, DTC, marketplace | 16-26 weeks |
| Gulf Cooperation Council | Dubai, Riyadh | Retail, distributor, DTC | 20-30 weeks |
| Asia Pacific | Singapore, Seoul, Sydney | Retail, marketplace, DTC | 18-30 weeks |
Lead time runs from signed scope to first revenue in market. It assumes product is finished and stock is available.
What actually holds each one up
DACH
Regulatory and claim review is the long pole. Germany rewards patience and punishes vague substantiation.
Nordics
Small volumes, high loyalty, unusually strong local press. A good proving ground before a wider EU push.
France
Selective distribution and pharmacy channels operate on relationships that take a season to build.
Italy
Fashion and beauty run on the show calendar. Entry timing matters more here than in any other European market.
North America
The most expensive market to guess wrong in. We usually recommend a narrow regional or channel test before national.
Gulf Cooperation Council
Registration and ingredient approval run ahead of everything else. Distribution is concentrated in a handful of groups.
Asia Pacific
Three very different entries under one heading. We scope each separately and rarely recommend doing them at once.
How we choose
We start from where the category already has demand you can measure, not from where the brand would like to be seen. A brand that sells well in one market has usually earned the right to one adjacent market, not five.
Sequencing beats breadth. One market done properly funds the next. Five markets started at once will all be half-funded and none of them will produce clean data about what worked.
If we think you are entering a market too early, we will say so on the first call. That is not a sales technique. Entering the Gulf before your registrations are scoped or North America before you can afford a national media weight costs more than waiting.
Which market are you looking at?
Tell us the brand and the target. The first call is scoping, not a pitch.